AU
Arthritis UK (formerly Versus Arthritis)

Translational Call 2027

Funds UK translational projects developing new technology for people with arthritis.

The outline application must include a short project description, evidence of patient and public involvement and engagement (PPIE) plans, and an explanation of the project's relevance to the charity's own priorities, alongside proof that the applicant has already engaged their institution's Technology Transfer Office and thought through a route to commercialisation. People with lived experience of

The call funds Proof of Concept projects developing commercially viable technology that benefits people with arthritis, across areas like medical devices, orthotics, implantable therapeutic delivery, diagnostics, imaging, cell and regenerative therapy, and novel small-molecule or biologic therapeutics. Projects should already be far enough along that they need further validation of the technical, market or commercial concept to attract industry investment, not early-stage exploration.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.28 Oct 2026
Decision timeiTypical time from the deadline to the funder's decision.10 weeks
Project durationiHow long the funded work is expected to run.1–24 months
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →